Empagliflozin reduces podocyte lipotoxicity in experimental Alport syndrome.
Ge M, Molina J, Kim JJ, Mallela SK, Ahmad A, Varona Santos J, Al-Ali H, Mitrofanova A, Sharma K, Fontanesi F, Merscher S, Fornoni A.
Ge M, et al. Among authors: fontanesi f.
Elife. 2023 May 2;12:e83353. doi: 10.7554/eLife.83353.
Elife. 2023.
PMID: 37129368
Free PMC article.